Siga Technologies, Inc.

New York, NY

UEI
VJRNRTSL22K4
CAGE
1V4X4
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
31 E 62nd St, New York, NY 10065, USA
Website
siga.com
Founded
1995
Employees
11-50
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Siga Technologies, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Procurement of 23,030 tpoxx oral courses and 50 tpoxx IV courses. To maintain national stockpile. Contract · W911SR24C0030 ACC Aberdeen Proving Ground $8,999,677
Procure up to 23000 tpoxx courses for small POX treatment. Contract · W911SR22C0051 ACC Aberdeen Proving Ground $11,752,417
Procure courses of FDA approved tpoxx drug/therapeutic Contract · W911SR22C0032 ACC Aberdeen Proving Ground $7,469,638
Procurement and late-stage development of smallpox antiviral drug(s) Contract · 75A50118C00019 Office of the Assistant Secretary for Preparedness and Response $626,506,870
Drugs and biologicals Contract · HHSO100201100001C Office of the Assistant Secretary for Preparedness and Response $518,482,778

About Siga Technologies, Inc.

Siga Technologies, Inc. is a for-profit corporate entity registered in SAM.gov since 2001, specializing in the manufacturing of pharmaceutical products with a focus on biodefense medical countermeasures. The company is primarily known for developing TPOXX (tecovirimat), an FDA-approved therapeutic medication used for treating smallpox and related viral infections. Based in New York, Siga Technologies has established itself as a key provider of specialized medical treatments for potential biological threat scenarios, with a significant portion of its business centered on supplying critical medical countermeasures to U.S. government agencies.

The company has consistently secured federal contract awards from the Department of Defense, specifically the Joint PEO Chemical and Biological Defense agency, for procuring courses of TPOXX. Recent contract awards demonstrate a pattern of supplying strategic medical stockpiles, including contracts for 23,030 oral and 50 intravenous TPOXX courses in August 2024, 23,000 TPOXX courses in September 2022, and 10,000 TPOXX courses in May 2022. These contracts, valued between $7.4 million and $11.7 million, are definitive firm fixed-price agreements with no specific small business set-aside designations. The contracts uniformly aim to replenish and maintain national medical stockpiles, focusing on therapeutic treatments for potential biological threats, particularly smallpox. Each contract has been awarded on a sole-source basis, highlighting Siga Technologies' unique position as the sole FDA-approved provider of this specific therapeutic treatment.

Quick answers

What is Siga Technologies, Inc.'s UEI?

Siga Technologies, Inc.'s Unique Entity ID (UEI) in SAM.gov is VJRNRTSL22K4.

What is Siga Technologies, Inc.'s CAGE code?

Siga Technologies, Inc.'s CAGE code is 1V4X4.

What is Siga Technologies, Inc.'s primary NAICS code?

Siga Technologies, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Siga Technologies, Inc. located?

Siga Technologies, Inc.'s physical address in SAM.gov is 31 E 62nd St, New York, NY 10065, USA.

Is Siga Technologies, Inc. registered in SAM.gov?

Yes. Siga Technologies, Inc.'s SAM.gov registration is active through May 18, 2027.

What is Siga Technologies, Inc.'s most recent federal award?

Siga Technologies, Inc.'s most recent federal contract award is Procurement of 23,030 tpoxx oral courses and 50 tpoxx IV courses. To maintain national stockpile (W911SR24C0030), from ACC Aberdeen Proving Ground, on August 2, 2024.

On GovTribe

See Siga Technologies, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors